Assessing the feasibility of replacing AMH for oligo/amenorrhea or hyperandrogenism with further studies, addressing the current laboratory and other challenges of AMH measurement, and further clarifying the pathophysiology of PCOS may allow serum AMH to be a useful diagnostic test for women with polycystic ovary syndrome. This evidence concerns the gene AMH and hyperandrogenism.